2 completed, 1 no longer available, 1 unknown. 2 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Completed 2 |
| Phase 2 | 1 | Unknown 1 |
Follow arbekacin: new trials by email Literature Review of arbekacin trials Research Report on arbekacin
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Intrapulmonary Pharmacokinetics of ME1100 in Healthy Volunteers ME1100 inhalation solution - Healthy | Phase 1 | Completed | Meiji Seika Pharma Co., Ltd. | 42 | 2013-09-01 | 2014-06-12 |
| Phase II Study of NPC-14 (Arbekacin Sulfate) to Explore Safety, Tolerability, and Efficacy in Duchenne Muscular Dystrophy NPC-14, Placebo - Muscular Dystrophy, Duchenne | Phase 2 | Unknown | Kobe University | 21 | 2013-08-01 | 2015-09-03 |
| Pharmacokinetics and Safety Study of ME1100 in Healthy Volunteers ME1100 inhalation solution, ME1100 placebo inhalation solution - Healthy | Phase 1 | Completed | Meiji Seika Pharma Co., Ltd. | 56 | 2013-07-01 | 2014-06-12 |
| Arbekacin Treatment of Adult Patients With Infections Caused by Multidrug-resistant Bacteria Arbekacin Sulfate - Infection Due to Resistant Organism | No longer available | U.S. Army Medical Research and Development Command | 2020-01-02 |
Muscular Dystrophy, Duchenne (1)
Meiji Seika Pharma Co., Ltd. (2) · Kobe University (1) · U.S. Army Medical Research and Development Command (1)
United States (3) · Japan (1)
Mitsuharu Egawa (2) · Hirofumi Komaki, MD, PhD (1) · Michael Zapor, MD, PhD (1) · Yasuhiro Takeshima, MD, PhD (1)